71 – 80 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
The European Vasculitis Society 2016 Meeting Report
(
- Contribution to journal › Article
-
Mark
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
(
- Contribution to journal › Article
- 2016
-
Mark
The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)
(
- Contribution to journal › Scientific review
-
Mark
Neutrophil extracellular traps in ANCA-associated vasculitis
(
- Contribution to journal › Scientific review
-
Mark
Home- or Institutional Hemodialysis? - a Matched Pair-Cohort Study Comparing Survival and Some Modifiable Factors Related to Survival
(
- Contribution to journal › Article
-
Mark
Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population
(
- Contribution to journal › Article
-
Mark
Rituximab for treatment of severe renal disease in ANCA associated vasculitis
(
- Contribution to journal › Article
-
Mark
Long-term kidney transplant outcomes in primary glomerulonephritis : Analysis from the ERA-EDTA registry
(
- Contribution to journal › Article
-
Mark
Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period
(
- Contribution to journal › Article